These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4246651)

  • 1. Combination chemotherapy in gastrointestinal cancer.
    Reitemeier RJ; Moertel CG; Hahn RG
    Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral administration of fluorouracil. A preliminary trial.
    Nadler SH
    Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.
    De Jager RL; Magill GB; Golbey RB; Krakoff IH
    Cancer Treat Rep; 1976 Sep; 60(9):1373-5. PubMed ID: 1016970
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
    Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
    Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
    Moertel CG; Rubin J; O'Connell MJ; Schutt AJ; Wieand HS
    J Clin Oncol; 1986 Jul; 4(7):1053-7. PubMed ID: 3014083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Digestive tract cancer: planning of chemotherapy].
    Hara Y; Tobita Y
    Nihon Rinsho; 1975 May; 33(5):1825-32. PubMed ID: 1171277
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical management of advanced gastrointestinal cancer.
    Moertel C
    Semin Drug Treat; 1973; 3(1):55-68. PubMed ID: 4351814
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
    [No Abstract]   [Full Text] [Related]  

  • 9. [A clinical study of N-nitrosomethylurea].
    Vermel' EM; Korman NP; Milonov BV; Evseenko LS; Orlova RS
    Vopr Onkol; 1970 May; 16(5):31-7. PubMed ID: 4915916
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Reitemeier RJ; Schutt AJ; Hahn RG
    Cancer Chemother Rep; 1971 Jun; 55(3):303-7. PubMed ID: 5115851
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of advanced gastrointestinal cancer with 1-3-bis-(2-chlorethyl)-1-nitrosourea (BCNU).
    Moertel CG; Reitemeier RJ; Hahn RG
    Clin Pharmacol Ther; 1968; 9(5):652-6. PubMed ID: 5676805
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
    Gailani S; Holland JF; Falkson G; Leone L; Burningham R; Larsen V
    Cancer; 1972 May; 29(5):1308-13. PubMed ID: 4623252
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
    Hill GJ; Grage TB; Wilson W; Ansfield FJ
    J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
    Tormey DC; Gailani S; Leone L
    Oncology; 1974; 29(3):244-8. PubMed ID: 4415043
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral methotrexate therapy of gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG
    Surg Gynecol Obstet; 1970 Feb; 130(2):292-4. PubMed ID: 4189074
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical study of fluorouracil.
    Nadler SH; Moore GE
    Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
    Van Dyk JJ; Clarkson BD; Duschinsky R; Keller O; La Sala E; Krakoff IH
    Cancer Res; 1967 Nov; 27(11):2129-36. PubMed ID: 4294532
    [No Abstract]   [Full Text] [Related]  

  • 20. [A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)].
    Queisser W; Schaefer J; Arnold H; Drings P; Geldmacher J; Hartwich G; Kredel L; Mayer M; Neidhardt B; von Oldershausen HF; Rösch W; Wahrendorf J
    Dtsch Med Wochenschr; 1979 Aug; 104(35):1231. PubMed ID: 383437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.